Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman

19 March 2025

Interview

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Jason Dowd

18 March 2025

Interview

Developing autologous iPSC-based therapies for Parkinson’s disease treatment

Kim Raineri

28 February 2025

Interview

Driving innovation in cell and gene therapy: the role of AI and robotics

Kenneth Harris, Mitchel Sivilotti, Anthony Rotunno

27 January 2025

Interview

What removing the DNA synthesis bottleneck means for the future of drug discovery and development

Elizabeth Wood

14 January 2025

Interview

Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently

Xueyuan Liu

19 December 2024

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

05 December 2024

Interview

Troubleshooting process and analytical tool changes in an approved ATMP process

Maitane Ortiz, Marta Malo De Molina

03 December 2024

Interview

Process optimization for AAV-based gene therapy: insights on downstream purification

Srivatsan Ramesh

17 October 2024

Interview

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Arindam Mitra

02 October 2024

Interview

Advancing CAR-T therapies: navigating innovation, challenges, and the future of biopharma analytics

Adam Fung

09 September 2024

Interview

Driving digital innovation for supply chain orchestration in cell and gene therapy

Christian Fuchs

28 August 2024

Interview

Streamlining cell and gene therapy supply chains: using semi-automation and AI for cost reduction

Stephan Kadauke

30 July 2024

Interview

Delving into the unknowns of mRNA-LNP formulation and characterization

Ramesh Marasini

15 July 2024

Interview

Exploring analytical assays and CMC challenges for viral vector-based therapies

Vladimir Slepushkin

19 June 2024

Interview

Revolutionizing AAV manufacturing: innovations in process and capsid development

Michael DiBiasio-White

03 June 2024

Interview

Planning for success with an allogeneic Treg cell sourcing strategy

Matthew Breton

23 May 2024

Interview

Weighing up the pros and cons of adopting a piecemeal versus a full automation approach to cell therapy manufacture

Raymond Luke

21 May 2024

Interview

Fit for function: developing potency assays reflective of the in vivo environment

Giorgio Zenere, Dirk Windgassen

10 May 2024

Interview

Gene therapy is having a monumental year: how can the industry keep up with supply?

Suman Subramanian

04 April 2024

Interview

Achieving scalability: strategic insights into avoiding the pitfalls of the cell and gene therapy supply chain

Donna Rill

19 March 2024

Interview